Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alkayed, N. J.
Right arrow Articles by Miller, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alkayed, N. J.
Right arrow Articles by Miller, V. M.

(Stroke. 2000;31:161.)
© 2000 American Heart Association, Inc.


Original Contributions

Neuroprotective Effects of Female Gonadal Steroids in Reproductively Senescent Female Rats

Nabil J. Alkayed, MD, PhD; Stephanie J. Murphy, VMD, PhD; Richard J. Traystman, PhD Patricia D. Hurn, PhD

From the Department of Anesthesiology and Critical Care Medicine (N.J.A., R.J.T., P.D.H.) and Division of Comparative Medicine (S.J.M.), Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Nabil J. Alkayed, MD, PhD, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, 600 N Wolfe St, Blalock 1404, Baltimore, MD 21287. E-mail nalkayed{at}jhmi.edu

Background and Purpose—Young adult female rats sustain smaller infarcts after experimental stroke than age-matched males. This sex difference in ischemic brain injury in young animals disappears after surgical ovariectomy and can be restored by estrogen replacement. We sought to determine whether ischemic brain injury continues to be smaller in middle-aged, reproductively senescent female rats compared with age-matched males and to test the effect of ovarian steroids on brain injury after experimental stroke in females.

Methods—Four groups of 16-month old Wistar rats (males [n=9], untreated females [n=9], and females pretreated with 17ß-estradiol [25-µg pellets administered subcutaneously for 7 days; n=9] or progesterone [10-mg pellets administered subcutaneously for 7 days; n=9] were subjected to 2 hours of middle cerebral artery occlusion with the intraluminal filament technique, followed by 22 hours of reperfusion. Physiological variables and laser-Doppler cerebral cortical perfusion were monitored throughout ischemia and early reperfusion. In a separate cohort of males (n=3), untreated females (n=3), females pretreated with 17ß-estradiol (n=3), and females pretreated with progesterone (n=3), end-ischemic regional cerebral blood flow was measured by [14C]iodoantipyrine autoradiography.

Results—As predicted, infarct size was not different between middle-aged male and female rats. Cortical infarcts were 21±5% and 31±6% of ipsilateral cerebral cortex, and striatal infarcts were 44±7% and 43±5% of ipsilateral striatum in males and females, respectively. Both estrogen and progesterone reduced cortical infarct in reproductively senescent females (5±2% and 16±4% in estrogen- and progesterone-treated groups, respectively, compared with 31±6% in untreated group). Striatal infarct was smaller in the estrogen- but not in the progesterone-treated group. Relative change in laser-Doppler cerebral cortical perfusion from preischemic baseline and absolute end-ischemic regional cerebral blood flow were not affected by hormonal treatments.

Conclusions—We conclude that the protection against ischemic brain injury found in young adult female rats disappears after reproductive senescence in middle-aged females and that ovarian hormones alleviate stroke injury in reproductively senescent female rats by a blood flow–independent mechanism. These findings support a role for hormone replacement therapy in stroke injury prevention in postmenopausal women.

Editorial Comment

Virginia M. Miller, PhD, Guest Editor

Department of Surgery Mayo Clinic Rochester, Minnesota




This article has been cited by other articles:


Home page
NeuroscientistHome page
C. L Gibson, B. Coomber, and J. Rathbone
Is Progesterone a Candidate Neuroprotective Factor for Treatment following Ischemic Stroke?
Neuroscientist, August 1, 2009; 15(4): 324 - 332.
[Abstract] [PDF]


Home page
Physiol. GenomicsHome page
A. R. Mendenhall, M. G. LeBlanc, D. P. Mohan, and P. A. Padilla
Reduction in ovulation or male sex phenotype increases long-term anoxia survival in a daf-16-independent manner in Caenorhabditis elegans
Physiol Genomics, February 2, 2009; 36(3): 167 - 178.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. Vagnerova, I. P. Koerner, and P. D. Hurn
Gender and the Injured Brain
Anesth. Analg., July 1, 2008; 107(1): 201 - 214.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
S. Renolleau, S. Fau, and C. Charriaut-Marlangue
Gender-Related Differences in Apoptotic Pathways After Neonatal Cerebral Ischemia
Neuroscientist, February 1, 2008; 14(1): 46 - 52.
[Abstract] [PDF]


Home page
BrainHome page
C. L. Gibson, L. J. Gray, P. M. W. Bath, and S. P. Murphy
Progesterone for the treatment of experimental brain injury; a systematic review
Brain, February 1, 2008; 131(2): 318 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Dziennis, T. Jia, O. K. Ronnekleiv, P. D. Hurn, and N. J. Alkayed
Role of Signal Transducer and Activator of Transcription-3 in Estradiol-Mediated Neuroprotection
J. Neurosci., July 4, 2007; 27(27): 7268 - 7274.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Vasudevan and D. W. Pfaff
Membrane-Initiated Actions of Estrogens in Neuroendocrinology: Emerging Principles
Endocr. Rev., February 1, 2007; 28(1): 1 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. N. Krause, S. P. Duckles, and D. A. Pelligrino
Influence of sex steroid hormones on cerebrovascular function
J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. D. Hilton, L. L. Bambrick, S. M. Thompson, and M. M. McCarthy
Estradiol Modulation of Kainic Acid-Induced Calcium Elevation in Neonatal Hippocampal Neurons
Endocrinology, March 1, 2006; 147(3): 1246 - 1255.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
M. T. Littleton-Kearney, J. M. Gaines, K. P. Callahan, S. J. Murphy, and P. D. Hurn
Effects of Estrogen on Platelet Reactivity After Transient Forebrain Ischemia in Rats
Biol Res Nurs, October 1, 2005; 7(2): 135 - 145.
[Abstract] [PDF]


Home page
JBJSHome page
L. L. Tosi, B. D. Boyan, and A. L. Boskey
Does Sex Matter in Musculoskeletal Health? The Influence of Sex and Gender on Musculoskeletal Health
J. Bone Joint Surg. Am., July 1, 2005; 87(7): 1631 - 1647.
[Full Text] [PDF]


Home page
StrokeHome page
C.-H. Chen, T. J.K. Toung, P. D. Hurn, R. C. Koehler, and A. Bhardwaj
Ischemic Neuroprotection With Selective {kappa}-Opioid Receptor Agonist Is Gender Specific
Stroke, July 1, 2005; 36(7): 1557 - 1561.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. M. Dhandapani, F. M. Wade, V. B. Mahesh, and D. W. Brann
Astrocyte-Derived Transforming Growth Factor-{beta} Mediates the Neuroprotective Effects of 17{beta}-Estradiol: Involvement of Nonclassical Genomic Signaling Pathways
Endocrinology, June 1, 2005; 146(6): 2749 - 2759.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. W. Rau, D. B. Dubal, M. Bottner, L. M. Gerhold, and P. M. Wise
Estradiol Attenuates Programmed Cell Death after Stroke-Like Injury
J. Neurosci., December 10, 2003; 23(36): 11420 - 11426.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Z. Zhang, T.-Y. Chen, J. R. Kirsch, T. J. K. Toung, R. J. Traystman, R. C. Koehler, P. D. Hurn, and A. Bhardwaj
Kappa-Opioid Receptor Selectivity for Ischemic Neuroprotection with BRL 52537 in Rats
Anesth. Analg., December 1, 2003; 97(6): 1776 - 1783.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. W. Rau, D. B. Dubal, M. Bottner, and P. M. Wise
Estradiol Differentially Regulates c-Fos after Focal Cerebral Ischemia
J. Neurosci., November 19, 2003; 23(33): 10487 - 10494.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. D. McCullough, K. Blizzard, E. R. Simpson, O. K. Oz, and P. D. Hurn
Aromatase Cytochrome P450 and Extragonadal Estrogen Play a Role in Ischemic Neuroprotection
J. Neurosci., September 24, 2003; 23(25): 8701 - 8705.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
N Nathoo, R Chetty, J R van Dellen, and G H Barnett
Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Mol. Pathol., June 1, 2003; 56(3): 132 - 136.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Goyagi, T. J.K. Toung, J. R. Kirsch, R. J. Traystman, R. C. Koehler, P. D. Hurn, and A. Bhardwaj
Neuroprotective {kappa}-Opioid Receptor Agonist BRL 52537 Attenuates Ischemia-Evoked Nitric Oxide Production In Vivo in Rats
Stroke, June 1, 2003; 34(6): 1533 - 1538.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. D. Hurn and L. M. Brass
Estrogen and Stroke: A Balanced Analysis
Stroke, February 1, 2003; 34(2): 338 - 341.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. M. Dhandapani and D. W. Brann
Protective Effects of Estrogen and Selective Estrogen Receptor Modulators in the Brain
Biol Reprod, November 1, 2002; 67(5): 1379 - 1385.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. J. Alkayed, T. Goyagi, H.-D. Joh, J. Klaus, D. R. Harder, R. J. Traystman, and P. D. Hurn
Neuroprotection and P450 2C11 Upregulation After Experimental Transient Ischemic Attack
Stroke, June 1, 2002; 33(6): 1677 - 1684.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. J. Alkayed, S. Goto, N. Sugo, H.-D. Joh, J. Klaus, B. J. Crain, O. Bernard, R. J. Traystman, and P. D. Hurn
Estrogen and Bcl-2: Gene Induction and Effect of Transgene in Experimental Stroke
J. Neurosci., October 1, 2001; 21(19): 7543 - 7550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Zhai, T. E. Eurell, R. P. Cotthaus, E. H. Jeffery, J. M. Bahr, and D. R. Gross
Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1223 - H1232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Watanabe, M. T. Littleton-Kearney, R. J. Traystman, and P. D. Hurn
Estrogen restores postischemic pial microvascular dilation
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H155 - H160.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. D. Bushnell, G. P. Samsa, and L. B. Goldstein
Hormone replacement therapy and ischemic stroke severity in women: A case-control study
Neurology, May 22, 2001; 56(10): 1304 - 1307.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Harms, M. Lautenschlager, A. Bergk, J. Katchanov, D. Freyer, K. Kapinya, U. Herwig, D. Megow, U. Dirnagl, J. R. Weber, et al.
Differential Mechanisms of Neuroprotection by 17 {beta}-Estradiol in Apoptotic versus Necrotic Neurodegeneration
J. Neurosci., April 15, 2001; 21(8): 2600 - 2609.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. D. McCullough, N. J. Alkayed, R. J. Traystman, M. J. Williams, and P. D. Hurn
Postischemic Estrogen Reduces Hypoperfusion and Secondary Ischemia After Experimental Stroke
Stroke, March 1, 2001; 32(3): 796 - 802.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. B. Dubal and P. M. Wise
Neuroprotective Effects of Estradiol in Middle-Aged Female Rats
Endocrinology, January 1, 2001; 142(1): 43 - 48.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Krejza, Z. Mariak, M. Huba, S. Wolczynski, and J. Lewko
Effect of Endogenous Estrogen on Blood Flow Through Carotid Arteries
Stroke, January 1, 2001; 32(1): 30 - 36.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. I. Rossberg, S. J. Murphy, R. J. Traystman, P. D. Hurn, and H. A. Kontos
LY353381.HCl, a Selective Estrogen Receptor Modulator, and Experimental Stroke Editorial Comment
Stroke, December 1, 2000; 31(12): 3041 - 3046.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. K. Toung, P. D. Hurn, R. J. Traystman, F. E. Sieber, and F. M. Faraci
Estrogen Decreases Infarct Size After Temporary Focal Ischemia in a Genetic Model of Type 1 Diabetes Mellitus Editorial Comment
Stroke, November 1, 2000; 31(11): 2701 - 2706.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. M. Wise and D. B. Dubal
Estradiol Protects Against Ischemic Brain Injury in Middle-Aged Rats
Biol Reprod, October 1, 2000; 63(4): 982 - 985.
[Abstract] [Full Text]


Home page
StrokeHome page
A. Bhardwaj, I. Harukuni, S. J. Murphy, N. J. Alkayed, B. J. Crain, R. C. Koehler, P. D. Hurn, R. J. Traystman, and J. C. Watson
Hypertonic Saline Worsens Infarct Volume After Transient Focal Ischemia in Rats Editorial Comment
Stroke, July 1, 2000; 31(7): 1694 - 1701.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. J. Murphy, R. J. Traystman, P. D. Hurn, and S. P. Duckles
Progesterone Exacerbates Striatal Stroke Injury in Progesterone-Deficient Female Animals Editorial Comment
Stroke, May 1, 2000; 31(5): 1173 - 1178.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Sampei, S. Goto, N. J. Alkayed, B. J. Crain, K. S. Korach, R. J. Traystman, G. E. Demas, R. J. Nelson, P. D. Hurn, and S. Piper Duckles
Stroke in Estrogen Receptor-{alpha}-Deficient Mice • Editorial Comment
Stroke, March 1, 2000; 31(3): 738 - 744.
[Abstract] [Full Text] [PDF]